[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.125.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1994

Carbamazepine Increases Cerebrospinal Fluid Thyrotropin-Releasing Hormone Levels in Affectively Ill Patients

Author Affiliations

From the Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Md (Drs Marangell, George, Pazzaglia, Huggins, and Post); and Department of Psychiatry, Duke University Medical Center, Durham, NC (Dr Bissette). Dr Marangell is now with the Department of Psychiatry, Baylor College of Medicine, Houston, Tex.

Arch Gen Psychiatry. 1994;51(8):625-628. doi:10.1001/archpsyc.1994.03950080037005
Abstract

Background:  Thyrotropin-releasing hormone is an endogenous tripeptide with endocrine-independent neurophysiologic properties that may be relevant to affective or seizure disorders. We studied the effect of carbamazepine, which has both mood-stabilizing and anticonvulsant properties, on cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.

Method:  Paired cerebrospinal fluid samples were collected from nine inpatients with mood disorders, both while medication free and while taking carbamazepine for an average of longer than 1 month at 950 mg/d, achieving blood levels of 8.8 mg/L.

Results:  Carbamazepine treatment was consistently and significantly associated with increased cerebrospinal fluid thyrotropin-releasing hormone levels (P<.0001).

Conclusion:  As carbamazepine-induced increases in thyrotropin-releasing hormone levels could be relevant to either its psychotropic or anticonvulsant properties, further clinical and preclinical investigation of this finding appears indicated.

×